Related Experiment Videos
[Photodermatosis induced by hydroxychloroquine: 4 cases]
I Métayer1, X Balguerie, P Courville
1Clinique Dermatologique, Hôpital Charles Nicole, 1, rue de Germont, 76031 Rouen Cedex.
Annales De Dermatologie Et De Venereologie
|July 19, 2001
Summary
Hydroxychloroquine, an antimalarial drug, can rarely cause photodermatosis, leading to light-sensitive skin reactions. Discontinuation of hydroxychloroquine typically resolves these adverse effects.
Area of Science:
- Dermatology
- Pharmacology
- Toxicology
Context:
- Hydroxychloroquine (HCQ) is widely used in dermatology for its photo-protective properties.
- However, rare instances of photosensitivity reactions to HCQ have been documented.
- Understanding these adverse effects is crucial for patient safety and effective treatment.
Purpose:
- To report four cases of photodermatosis induced by hydroxychloroquine.
- To analyze the clinical presentation, causative factors, and outcomes of these reactions.
- To differentiate HCQ-induced photodermatosis from underlying photodermatoses.
Summary:
- Four patients developed photolocalized eruptions after initiating hydroxychloroquine, with onset ranging from 6 days to 10 weeks.
- Minimal erythemal dose testing showed decreased tolerance to UV radiation during eruptions, normalizing after HCQ cessation.
- Hydroxychloroquine was deemed the primary cause in three cases; one case involved co-imputability with other medications. All patients improved after discontinuing HCQ.
Impact:
- This study highlights the rare but significant risk of photosensitivity reactions associated with hydroxychloroquine.
- It emphasizes the importance of considering drug-induced photodermatosis in patients presenting with light-sensitive eruptions.
- The findings aid clinicians in differential diagnosis and managing adverse reactions to hydroxychloroquine.